- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04998721
Uma Abordagem Diádica para a Depressão Perinatal na Atenção Primária: Materno-Infantil e Cuidados Diádicos (MInD)
Uma Abordagem Diádica para a Depressão Perinatal na Atenção Primária: Materno-Infantil e Cuidados Diádicos (MInD)
The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Eligible and consenting participants will be randomized in a single blind manner (research visitor will be blinded to condition) at a 1:1 ratio to either MInD (parenting intervention and usual integrated care) or usual integrated care in their second trimester of pregnancy. Research assessments will be administered during pregnancy and post-partum.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98195
- Amritha Bhat
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- English speaking pregnant women between gestational age (GA) 13 - 24 weeks
- ≥ 18 years,
- EPDS score ≥10,
- Ability to send and receive text messages (TM)
Exclusion Criteria:
- Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST).
- Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS.
- Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review);
- Multiple gestation (assessed by self-report and medical record);
- Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Maternal Infant Dyadic Care
Perinatal integrated care and Promoting First Relationships-Brief |
A brief version of the evidence based Promoting First Relationships (PFR) parenting intervention in which a parent is supported in appropriate interpretation of infant cues and in developing skills to effectively parent an infant. Sessions consist of reflective content (observing and reflecting back to the mother on patterns of dyadic interaction) and informational handouts. Reflective content will be delivered in person, and text messaging protocol will deliver informational content at developmentally appropriate times. PFR-B sessions are delivered in primary care settings beginning in the third trimester and continuing postpartum. Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction. |
|
Comparador Ativo: Control
Perinatal integrated care only |
Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change From Baseline in Perinatal Depression on the PHQ-9
Prazo: Baseline, 3 Months Postpartum, 6 Months Postpartum
|
The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period. |
Baseline, 3 Months Postpartum, 6 Months Postpartum
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)
Prazo: Baseline, 3 Months Postpartum, 6 Months Postpartum
|
The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112. |
Baseline, 3 Months Postpartum, 6 Months Postpartum
|
|
Change From Postpartum Baseline in Dyadic Interaction
Prazo: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
|
The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior. |
6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
|
|
Change From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
Prazo: Baseline, 3 Months Postpartum, 6 Months Postpartum
|
WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48. Higher scores indicate higher disability, that is higher values indicate a worse outcome. |
Baseline, 3 Months Postpartum, 6 Months Postpartum
|
|
Change From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)
Prazo: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
|
The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome. |
6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time
Prazo: Prenatal to 6 months PP
|
The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome. |
Prenatal to 6 months PP
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Amritha S Bhat, MD, MPH, University of Washington
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- STUDY00011405
- 1R34MH124798-01 (Concessão/Contrato do NIH dos EUA)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .